Application 203313

Type
BLA
Sponsor
NOVO

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
203313Ryzodeg 70/30insulin degludec and insulin aspart351(a)Disc2026-07-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RYZODEG 70/30INSULIN ASPART; INSULIN DEGLUDECSOLUTION;SUBCUTANEOUS90 UNITS/3ML;210 UNITS/3ML (30 UNITS/ML;70 UNITS/ML)NoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
72294SUPPL2022-10-11
72273SUPPL2022-10-07
62409APPL2020-04-01
60949SUPPL2020-03-23
60948SUPPL2020-03-23
60878SUPPL2020-03-23
60877SUPPL2020-03-23
55156SUPPL2020-03-23
55148SUPPL2020-03-23
51191ORIG2020-03-23
51190ORIG2020-03-23
51187ORIG2020-03-23
46474SUPPL2020-03-23
46224SUPPL2020-03-23
40287SUPPL2020-03-23
32408ORIG2020-03-23
22920ORIG2020-03-23
19453ORIG2020-03-23
63074ORIG1900-01-01
63073ORIG1900-01-01
63072ORIG1900-01-01
63071ORIG1900-01-01